File(s) under permanent embargo

Reason: 12 month publisher embargo from publication

Editorial for: The Effect of Tumor Size and Histology on Outcomes Following Segmentectomy vs. Lobectomy for Clinically Node-negative Non-small Cell Lung Cancer

journal contribution
posted on 10.09.2020 by Marius-Andrei Roman, Apostolos Nakas
Since the first lung resection for a tumour in 1861 by Pean1, thoracic surgery has evolved considerably and now offers patients widely available minimally invasive surgical options aimed at maintaining excellent oncological outcomes, while decreasing perioperative morbidity. The pursuit of further improvement of the disease free survival with an ever increasing multimorbidity population has led to the emergence of segmentectomy as the natural progression of parenchymal sparing techniques.2The current available evidence that compares segmentectomy with lobectomy in stage I non-small cell lung cancer (NSCLC) includes three randomised control trials (RCT), and several retrospective cohorts and meta-analyses. [opening paragraph]

History

Citation

Chest, in press

Author affiliation

Department of Cardiovascular Sciences

Version

AM (Accepted Manuscript)

Published in

Chest

Publisher

Elsevier

issn

0012-3692

Acceptance date

25/07/2020

Copyright date

2020

Publisher DOI

Language

en

Publisher version

https://www.sciencedirect.com/journal/chest

Exports

Logo branding

Categories

Exports